PEN-866 carries SN-38, an active metabolite of the topoisomerase inhibitor irinotecan, into the tumor and accumulates in the tumor by the selective binding of the small molecule with the intracellular target heat shock protein 90 (HSP90)
PEN-866 carries SN-38, an active metabolite of the topoisomerase inhibitor irinotecan, into the tumor and accumulates in the tumor by the selective binding of the small molecule with the intracellular target heat shock protein 90 (HSP90). for the treatment of this disease. In this review, we discuss recent advances in the use of drug conjugates…
